Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
General Hospital Products is a primary business segment of Baxter International, specializing in the manufacture and distribution of essential healthcare products used in clinical settings. The company's extensive portfolio includes intravenous (IV) solutions, infusion systems, pharmacy automation technologies, and clinical nutrition products. As a leader in the IV therapy market, GHP provides a wide range of pre-mixed drugs and delivery systems designed to improve patient safety and clinical efficiency. The segment focuses on advancing medication delivery through innovative drug-device combinations and automated pharmacy solutions that streamline hospital workflows. GHP's products are foundational to acute care, supporting critical treatments for dehydration, electrolyte imbalances, and systemic infections worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on General Hospital Products.